UNIGE document Scientific Article
previous document  unige:32498  next document
add to browser collection
Title

Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial

Authors
Zufferey, P
Published in Annals of the Rheumatic Diseases. 2012, vol. 71, no. 4, p. 560-2
Abstract Two subcutaneous injections of adalimumab in severe acute sciatica significantly reduced the number of back operations in a short-term randomised controlled clinical trial.
Keywords Acute DiseaseAdultAnti-Inflammatory Agents/administration & dosage/therapeutic useAntibodies, Monoclonal, Humanized/administration & dosage/therapeutic useBack Pain/etiologyDiskectomyDouble-Blind MethodFemaleFollow-Up StudiesHumansInjections, SubcutaneousKaplan-Meier EstimateMagnetic Resonance ImagingMaleMiddle AgedSciatica/complications/drug therapy/surgeryTreatment OutcomeTumor Necrosis Factor-alpha/antagonists & inhibitors
Identifiers
PMID: 21998121
Full text
Article (Published version) (110 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Mécanisme de l'inflammation articulaire (44)
Citation
(ISO format)
GENEVAY, Stéphane et al. Adalimumab in acute sciatica reduces the long-term need for surgery: a 3-year follow-up of a randomised double-blind placebo-controlled trial. In: Annals of the Rheumatic Diseases, 2012, vol. 71, n° 4, p. 560-2. https://archive-ouverte.unige.ch/unige:32498

232 hits

0 download

Update

Deposited on : 2013-12-18

Export document
Format :
Citation style :